English

BioStock: CLS starts new clinical study in prostate cancer

Report this content

Clinical Laserthermia Systems is in the midst of launching the TRANBERG Thermal Therapy System for minimally invasive image-guided focal laser ablation. Now, U.S. based HALO Precision Diagnostics  has shown interest in testing the system. The two companies are starting a study  in patients with prostate cancer, with the aim of starting to use it in some of HALO’s 16 clinics.

Read the article at biostock.se:

https://www.biostock.se/en/2023/11/cls-starts-new-clinical-study-in-prostate-cancer/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Subscribe

Documents & Links